2012
DOI: 10.1186/1471-2458-12-849
|View full text |Cite
|
Sign up to set email alerts
|

Excessive daytime sleepiness assessed by the Epworth Sleepiness Scale and its association with health related quality of life: a population-based study in China

Abstract: BackgroundExcessive daytime sleepiness (EDS) is a common condition worldwide that has many negative effects on people who were afflicted with it, especially on their health-related quality of life (HRQOL). The Epworth Sleepiness Scale (ESS) is a commonly used method for evaluating EDS in English-speaking countries. This paper reported the prevalence of subjective EDS in China as assessed by the Mandarin version of the ESS; tested the scale’s response rate, reliability and validity; and investigated the relatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
56
3
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
5
1
1

Relationship

1
6

Authors

Journals

citations
Cited by 65 publications
(65 citation statements)
references
References 47 publications
5
56
3
1
Order By: Relevance
“…On the other hand, in patients with OSAS, it has been observed a significant difference after using sham‐CPAP both in the degree of daytime hypersomnia and in several polysomnographic parameters: While hypersomnia improved 42, the quality of the sleep became worse (decreased sleep efficiency, increased time in stage 1 NREM sleep, and prolonged latency to REM sleep) 43. Therefore, taking into account the existing correlations between sleep quality, daytime hypersomnia, quality of life, and asthma control 44, 45, and the potential effect of sham‐CPAP in BHR 34, it cannot be excluded that subtherapeutic CPAP pressures, used as a placebo in asthmatic patients with OSAS, may have relevant effects on asthma outcomes that would distort the results of a controlled study. Finally, there are ethical issues regarding keeping patients with OSAS without active treatment, in patients with two potentially severe diseases.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, in patients with OSAS, it has been observed a significant difference after using sham‐CPAP both in the degree of daytime hypersomnia and in several polysomnographic parameters: While hypersomnia improved 42, the quality of the sleep became worse (decreased sleep efficiency, increased time in stage 1 NREM sleep, and prolonged latency to REM sleep) 43. Therefore, taking into account the existing correlations between sleep quality, daytime hypersomnia, quality of life, and asthma control 44, 45, and the potential effect of sham‐CPAP in BHR 34, it cannot be excluded that subtherapeutic CPAP pressures, used as a placebo in asthmatic patients with OSAS, may have relevant effects on asthma outcomes that would distort the results of a controlled study. Finally, there are ethical issues regarding keeping patients with OSAS without active treatment, in patients with two potentially severe diseases.…”
Section: Discussionmentioning
confidence: 99%
“…20 The Chinese version of ESS, modified Chinese version of the Rome II questionnaire (gastroduodenal, bowel, and biliary items only) and the Chinese version of Reflux Disease Questionnaire (RDQ) were applied to measure EDS, FGIDs, and GERD. 6,16,[21][22][23] The ESS is an 8-item, self-administered questionnaire covering eight situations commonly encountered in daily life. Each participant was instructed to answer how likely it is that he/she would fall asleep in different situations by giving a score ranging from 0 to 3.…”
Section: Measurementsmentioning
confidence: 99%
“…18 EDS is a common sleep-related symptom in China, it is more prevalent in the general Chinese population (22.2%) than in general American (8.7%) and Japanese populations (2.5%). [4][5][6] It is of interest whether EDS was associated with FGIDs. However, the relationship between EDS and FGIDs in the general population has not been systematically studied, especially in China.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations